Review and share useful Women’s Health brochures here.

A healthy and happy woman with a cellphone
Vaginitis | Brochures

BD Vaginal Panel Reimbursement and Market Access Toolkit

This toolkit serves as a guide on coding and the appeals process.

BD Patient profile Tianna
Cervical Cancer | Brochures

HPV 31 Patient profile

Tianna* is 35, has normal cytology and HPV 31. If she was your patient, what would you do? Learn how individually identifying HPV 31 can benefit your patients like Tianna.
Women's Health STIs
Vaginitis | Brochures

Get her vaginitis diagnosis right the first time with the BD Vaginal Panel

Learn more about how the BD Vaginal Panel provides a more accurate vaginitis diagnosis as compared to traditional methods.
Smiling woman smiling while painting
STIs | Vaginitis | Brochures

Vaginitis and STIs: The right treatment begins with the right diagnosis

Learn more about how the BD Vaginal Panel and the BD CTGCTV2 assay can help decrease the number of recurrent visits, incorrect treatments and negative sequelae associated with vaginits and STIs.
Child with woman smiling
Cervical Cancer | Brochures

Identify HPV 31 with BD Onclarity™ HPV Assay

Learn more about the importance of HPV 31 and the BD Onclarity™ HPV Assay with extended genotyping, the only FDA-approved HPV test that individually identifies HPV 31.
BD Onclarity™ HPV Assay with extended genotyping
Cervical Cancer | Brochures

BD Onclarity™ HPV Assay with extended genotyping

Learn more about the benefits of extended genotyping and the BD Onclarity™ HPV Assay, the only FDA-approved HPV test with extended genotyping, that identifies genotypes beyond 16 and 18, including 31.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

BD submits pre-market approval supplement to FDA to enable ThinPrep® Pap Test™ PreservCyt® Solution to be used with the BD Onclarity™ HPV Assay
Cervical Cancer | News & Updates
Press release: BD submits pre-market approval supplement to FDA to enable ThinPrep® Pap Test™ PreservCyt® Solution to be used with the BD Onclarity™ HPV Assay
Cervical Cancer Screening: The Current State of Testing
Cervical Cancer | Articles & Publications
Cervical Cancer Screening: The Current State of Testing
Contemporary OB/GYN
Cervical Cancer | News & Updates
Contemporary OB/GYN: Harris Poll study from BD reveals knowledge gap and inequity in HPV screening and cervical cancer